Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results on June 30, 2026
Northvale, New Jersey--(Newsfile Corp. - June 23, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced today that it will release its 2026 year-end financial results on Monday, June 29, 2026. Elite's management will host a live conference call on Tuesday, June 30th, at 11:30 AM EDT to discuss the company's financial and operating results and provide a general business update. St
Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-23 7:00 AM EDT | Elite Pharmaceuticals, Inc.
Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume
Toronto, Ontario--(Newsfile Corp. - June 23, 2026) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) ("Therma" or the "Company"), a developer and investment partner specializing in advanced medical device technologies, is pleased to announce continued sales momentum for its Venowave mobile compression device in the United States, highlighted by additional follow-on orders from Horizon Health USA ("Horizon") and from Gen-X Med. Building on the rapid deployment of previous ship
Technology, Biotechnology, Health
2026-06-23 6:30 AM EDT | Therma Bright Inc.
Custom Health Holdings Inc. to Commence Trading on the Toronto Stock Exchange
Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - Custom Health Holdings Inc. (TSX: CHLT) (formerly, Queue Ventures Ltd.) ("Custom Health" or the "Company"), further to its press release dated June 5, 2026, is pleased to announce that it has received final approval for listing on the Toronto Stock Exchange (the "TSX"). The common shares of the Company (CUSIP 23204J104 / ISIN CA23204J1049) ("Common Shares") will commence trading on the TSX un
Technology, Pharmaceuticals, Health
2026-06-22 5:45 PM EDT | Custom Health Holdings Inc.
CBD of Denver Announces Updated Corporate Website Reflecting Strategic Pivot into Artificial Intelligence
Cape Town, South Africa--(Newsfile Corp. - June 22, 2026) - CBD of Denver, Inc. (OTCID: CBDD), a publicly traded company, is pleased to announce that it has launched an updated corporate website at www.cbdofdenver-inc.com. The new website reflects the Company's exciting strategic transformation and its forward-looking direction as it actively explores merger and acquisition opportunities within the artificial intelli
Cannabis, Health, Cannabis Extractor, Cannabis Manufacturer
2026-06-22 10:53 AM EDT | CBD of Denver Inc.
BetterLife Pharma Secures CAD $2 Million in New Capital to Complete BETR-001 FDA IND Filing
Vancouver, British Columbia--(Newsfile Corp. - June 22, 2026) - BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FSE: NPAU) ("BetterLife" or the "Company") today announced it has closed a CAD $2,000,000 convertible debenture financing ("Debenture" or "Financing"). The Debenture will fund the remaining IND-enabling work on the Company's lead candidate, BETR-001, as BetterLife sharpens its focus on neurological pain indications, with an initial emphasis on cluster headache
2026-06-22 8:00 AM EDT | BetterLife Pharma Inc.
Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement
Houston, Texas--(Newsfile Corp. - June 22, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the beginning of a new commercial chapter for VitaCookies with the signing of its first licensing agreement. This milestone moves VitaCookies from internal development toward commercial execution, positioning the brand as a structured growth opportunity built on CBIH's formulations, operatio
Biotechnology, Pharmaceuticals, Cannabis, Health
2026-06-22 7:00 AM EDT | Cannabis Bioscience International Holdings
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company") announces that it has elected to voluntarily adopt semi-annual financial reporting and rely on the exemptions provided under Coordinated Blanket Order 51-933 - Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers ("CBO 51-933"). Introduced by the Canadian Securities Administrators ("CSA"), the pilot program under
Biotechnology, Pharmaceuticals, Health, Psychedelics
2026-06-19 12:16 PM EDT | Neural Therapeutics Inc.
Akanda Announces Receipt of Nasdaq Notice Regarding Minimum Stockholders' Equity Requirement
Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Akanda Corp. (NASDAQ: AKAN) (the "Company" or "Akanda"), today announced that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on June 16, 2026 indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2.5 million in stockholders' equity for continued listing
Cannabis, Health, Cannabis Cultivator, Cannabis Manufacturer
2026-06-18 5:00 PM EDT | Akanda Corp
Red Light Holland Reports Positive Preclinical Study Results for Coca in Weight Gain Prevention Post GLP-1 from Magdalena Biosciences, the Joint Venture Held Through Its Wholly Owned Subsidiary, Filament Health
Toronto, Ontario--(Newsfile Corp. - June 18, 2026) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland", "Red Light", or the "Company") is an Ontario based organization advancing innovation and research within the legal psychedelic sector. Following its acquisition of Filament Health Corp. ("Filament"), the Company has expanded it
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2026-06-18 9:01 AM EDT | Red Light Holland Corp.
Mobile-health Network Solutions Announces Change in Effective Date of Reverse Stock Split
Singapore, Singapore--(Newsfile Corp. - June 18, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health platform, today announced a one-for-six reverse stock split (the "Reverse Stock Split") of the Company's Class A Ordinary Shares ("common stock"), which will become effective at 12:01 a.m. Eastern Time on Monday, June 29, 2026. The Company had previously announced that the Reverse Stock Split w
2026-06-18 9:00 AM EDT | Mobile-health Network Solutions
UBERDOC Health Technologies Corp. Announces Proposed Corporate Name Change to Apptly Health Technologies Corp.
Boston, Massachusetts--(Newsfile Corp. - June 18, 2026) - UBERDOC Health Technologies Corp. (CSE: APPT) (FSE: 4KL0) (the "Company") is pleased to announce its intention to change its corporate name to Apptly Health Technologies Corp. ("Apptly"). The rebrand is expected to mark the next chapter in the Company's evolution, from a platform that helps patients book specialists into a leading marketplace for direct-pay healthcare in the United States. The Company's flagship consumer platform will
2026-06-18 8:30 AM EDT | Apptly Health Technologies Corp.
Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million
Markham, Ontario--(Newsfile Corp. - June 18, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, is pleased to announce, that due to strong investor demand, it has increased the size of its previously announced non-brokered private placement financing (the "Offering"). The Company now intends to issue up to 2,000,000 units of the Company (the "Units") at a price of $1.50 per Unit for aggregate gross procee
2026-06-18 7:30 AM EDT | Cheelcare Inc.
BioHarvest Sciences to Present at the 2026 BIO International Convention
British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details:
Biotechnology, Pharmaceuticals, Health
2026-06-18 7:30 AM EDT | BioHarvest Sciences Inc.
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
King of Prussia, Pennsylvania--(Newsfile Corp. - June 18, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio Pharmaceuticals announced today that Robert Bitterman, CEO and Chairman of the Board, will present an overview of the Company's INTASYL® siRNA platform, including its lead clinical candidate PH-762
Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health
2026-06-18 7:00 AM EDT | Phio Pharmaceuticals Corp.
Promino Expands U.S. NCAA Athlete Platform with Multi-Sport NIL Agreement with Every True Tiger
Promino expands its U.S. NCAA NIL platform with Every True Tiger, the third-party marketing arm of the Missouri Tigers, and select student-athletes across leading sports, including football, basketball, wrestling and others. The agreement follows Promino's recently announced VMI NIL partnership and marks another step in the Company's growth across U.S. Division I athletics. Promino continues building athlete-driven awareness behind flagship Promino NSF Ce
Food / Beverages, Sports, Health
2026-06-18 6:00 AM EDT | Promino Nutritional Sciences, Inc.
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand'
Technology, Biotechnology, Health
2026-06-18 6:00 AM EDT | Restart Life Sciences Corp.
Altus Copper Applies for Partial Revocation of Failure-to-File Cease Trade Order, Announces Proposed Financing and Provides Further Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - Altus Copper Corp. (the "Company") announces that it has applied to the British Columbia Securities Commission (the "BCSC") and the Ontario Securities Commission (the "OSC") for a partial revocation order (the "Partial Revocation Order") of the failure-to-file cease trade order jointly issued by the BCSC and the OSC on December 5, 2023 (the "FFCTO"). The Company further announces a proposed fina
Food / Beverages, Healthcare and Hospitals, Health
2026-06-17 5:30 PM EDT | Altus Copper Corp.
Hemostemix' $1,000,000 Private Placement and Update
Calgary, Alberta--(Newsfile Corp. - June 17, 2026) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce that the Company is closing up to $1,000,000 of financing in tranches from the sale of Units at $0.05 each. Each Unit shall consist of one Common Share in the capital of the Company ("Common Share") and one half common share purchase warrant ("1/2 Warrant"), with each whole Warrant (2 x 1/2 Warrants) entitling the holder to acquire one Common Share at a price of $
Biotechnology, Pharmaceuticals, Health
2026-06-17 5:22 PM EDT | Hemostemix Inc.
Tersis and Pingkas Meet with Freeport and Provincial Officials to Explore Potential Project in Bataan, Philippines
Brookville, Florida--(Newsfile Corp. - June 17, 2026) - Representatives from Tersis Technologies (OTCID: TERS) and Pingkas Capital recently met with Authority of the Freeport Area of Bataan (AFAB) administrator Hussein Pangandaman, the Public Private Partnership Investment Center (PPPIC) and their respective teams to discuss potential opportunities for the development of a waste-to-energy project within Bataan, Philippines.
Agriculture, Energy, Alternative Energy, Health
2026-06-17 2:59 PM EDT | Tersis Technologies Inc.
Plaza Capital Invests in Spring Loaded to Accelerate Global Expansion of Innovative Orthopedic Bracing
Halifax, Nova Scotia--(Newsfile Corp. - June 17, 2026) - Spring Loaded Technology Inc., a Canadian medical technology company pioneering novel orthopedic bracing and mobility solutions, today announced a strategic investment from Plaza Capital to support the company's next phase of growth, including international expansion, research and development, and continued advancement of evidence-based mobility solutions. The investment follows Spring Loaded's successful management-led buyout com
2026-06-17 7:00 AM EDT | Spring Loaded Technology